With several products currently in the clinic and a compelling long-term vision for our future, Facet Biotech is a small but sophisticated biotechnology company. Combining our expertise in antibody engineering with a disciplined, biology-driven research approach, our company is dedicated to advancing our current pipeline of four clinical-stage products and leveraging our research and development capabilities to identify and develop new drugs. We are passionate and committed about the work that we do, and we share a common goal of developing therapeutics that will improve people’s lives.

Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.

Company Overview Presentation
Our Promising Pipeline
Careers at Facet Biotech
Recent Publications